about
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodateUnderstanding and modulating mammalian-microbial communication for improved human health.The influence of non-steroidal anti-inflammatory drugs on the gut microbiomeRole of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease.Gut Microbiota Mediates Protection Against Enteropathy Induced by Indomethacin.The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues.Differential effects of selective and non-selective cyclooxygenase inhibitors on fecal microbiota in adult horses
P2860
Q28072437-75510CAE-CB7B-4ED7-B288-743198510175Q35026463-574FA9E8-233E-4D05-9B94-7C4DBEDDADF0Q35813554-070157DA-1AF3-49BC-BD29-FDF47A1A99E3Q38707937-7A94EA5A-A7CF-4B33-9837-CB592E7D5653Q38773030-7CA7A5D7-C56B-49BE-936E-7280F7FE13D4Q50054146-E038F43A-F1EC-4AE4-8B95-CCA675060B93Q58715584-0B918928-2B27-435F-99E1-8D6757C051E0
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
NSAID enteropathy: could probiotics prevent it?
@en
type
label
NSAID enteropathy: could probiotics prevent it?
@en
prefLabel
NSAID enteropathy: could probiotics prevent it?
@en
P2093
P2860
P1476
NSAID enteropathy: could probiotics prevent it?
@en
P2093
Antonella Gallo
Antonio Gasbarrini
Massimo Montalto
Raffaele Landolfi
P2860
P304
P356
10.1007/S00535-012-0648-2
P577
2012-08-09T00:00:00Z